Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...

After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU, and the EMA has started its review. The six-valent ...

S&P 500 earnings activity accelerated this week, with more than 130 index members reporting quarterly results that provided key insights into corporate margin health, spending trends, and overall ...

Bluesight and Pfizer partner to deliver RFID-tagged medications to hospitals, simplifying pharmacy workflows and improving ...

Takeda's orexin agonist Orzeyful has been approved in the US to treat narcolepsy type 1 (NT1) in adults, becoming the first ...

One of the beneficial characteristics of the response to the COVID-19 pandemic were pledges from companies involved in developing vaccines (such ...

Pfizer emerged as a pharmaceutical powerhouse during the pandemic, but lower infection rates and narrower use cases mean its Covid-19 brands are impacting the company’s bottom l ...

A U.K. marketing watchdog has reprimanded Sanofi for using “a highly misleading interpretation of data” to make disparaging claims about Pfizer’s respiratory syncytial virus (RSV) vaccine. The PMCPA, ...

Poland and Romania’s legal battles with Pfizer Inc. over unused Covid-19 vaccine purchases are spilling into the funding of the eastern European nations’ air traffic agencies. The Polish Air ...

Pfizer's stock price is rough 60% below its late 2021 high. In fact, the share price is lower today than it was prior to the coronavirus pandemic. That's actually quite important, because Pfizer was ...